Treatment of Attention Deficit Hyperactivity Disorder in Children and AdolescentsSafety Considerations

被引：0
作者：
Mark L. Wolraich
Laura McGuinn
Melissa Doffing
机构：
[1] University of Oklahoma Health Sciences Center,Department of Pediatrics, Section of Developmental and Behavioral Pediatrics
来源：
Drug Safety | 2007年 / 30卷
关键词：
Attention Deficit Hyperactivity Disorder; Sudden Cardiac Death; Methylphenidate; Attention Deficit Hyperactivity Disorder; Atomoxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Despite a large body of evidence for both the validity of the diagnosis of attention deficit hyperactivity disorder (ADHD) and the efficacy of its treatment with medication, there is an equally long history of controversy. This article focuses on presenting safety information for medications approved by the US FDA for the treatment of individuals with ADHD.
引用
收藏
页码：17 / 26
页数：9
相关论文
共 141 条
[1]  
Wolraich M(1999)Attention deficit hyperactivity disorder: the most studied yet most controversial diagnosis Ment Retard Dev Disabil Res Rev 5 163-8
[2]  
Bradley C(1937)The behavior of children receiving benzedrine A J of Psychiatry 94 577-85
[3]  
Conners CK(1966)The effects of dexedrine on rapid discrimination and motor control of hyperkinetic children under mild stress J Nerv Ment Dis 142 420-33
[4]  
Wolraich ML(1977)Stimulant drug therapy in hyperactive children: research and clinical implications Pediatrics 60 512-8
[5]  
Swanson JM(1993)Effect of stimulant medication on children with ADD: a “Review of Reviews” Exceptional Children 60 154-62
[6]  
McBurnett K(2001)How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolesents? A meta-analysis CMAJ 165 1475-88
[7]  
Wigal T(2002)A study of compliance with FDA precommendations for pemoline (Cylert) J Am Acad Child Adolesc Psychiatry 41 785-90
[8]  
Schachter H(2001)Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 108 e83-57
[9]  
Pham B(2002)Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder Pediatrics 110 e75-901
[10]  
King J(2004)A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD Eur Child Adolesc Psychiatry 13 249-8
12345678910